200+ Clinical Studies • 40+ Countries

Cerebrolysin: The Most Researched Neuropeptide

📄 2 PubMed citations

By , HighPeptides Editor

Last updated: March 2026

Cerebrolysin (FPF 1070) is a porcine brain-derived peptide mixture containing fragments of CNTF, GDNF, and NGF. With 200+ published clinical studies, it is approved for stroke, TBI, and dementia treatment in 40+ countries — including Russia, China, and much of Europe — though not in the United States. It has been used clinically since the 1950s.

0
IV/IM Dose
Per Day
0
Clinical Studies
Published
0
Countries
Approved
📋 On this page
  1. What Is Cerebrolysin?
  2. What the Research Shows
  3. Dosing & Administration
  4. Study Citations
  5. Key Takeaways
  6. 🛒 Recommended Products
  7. Related Resources
Background

What Is Cerebrolysin?

Cerebrolysin (FPF 1070) is a porcine brain-derived peptide mixture from EVER Neuro Pharma (Austria). Used clinically since the 1950s with extensive research across stroke, TBI, and dementia.

🧬
Neurotrophic Factor Content

Contains peptides including CNTF, GDNF, and NGF fragments. Derived from porcine brain tissue through enzymatic breakdown (1-10 kDa peptides).

🔄
Neuroprotective Mechanisms

Reduces excitotoxic damage, decreases amyloid-beta toxicity, promotes neuronal survival under hypoxia, modulates neuroinflammation.

🌱
Neuroplasticity Promotion

Promotes hippocampal neurogenesis, enhances synaptic plasticity, improves cholinergic neurotransmission.

💉
Administration

MUST be IV or IM injection. Oral is ineffective — peptides would be digested. Significant barrier vs oral nootropics.

Research

What the Research Shows

Meta-analyses of Cerebrolysin clinical trials.

📋

Context: Most trials from Eastern Europe/Russia where approved for decades. Volume is impressive but many studies older. FDA has not approved despite decades of use elsewhere.

Ischemic Stroke — Modified Rankin Scale
2023 Cochrane review (6 RCTs, ~1,600 participants) found no demonstrated benefit on death or disability, with a possible increase in non-fatal serious adverse events
No benefit
Vascular Dementia — MMSE Scores
Multiple RCTs show significant improvement vs placebo over 12-24 weeks
Positive
Alzheimer's Disease — ADAS-cog
Modest but significant benefits in mild-to-moderate AD
Modest
Traumatic Brain Injury Recovery
Improved functional outcomes in moderate TBI (studies from Eastern Europe)
Positive
Protocol

Dosing & Administration

Clinical protocols from published studies. Requires prescription and medical supervision.

💊
Standard Clinical Dose
  • 10-30mL per day, depending on indication
  • Administered via IV infusion or IM injection
  • Typical course: 10-20 daily infusions
  • Repeat courses possible after break
🏥
Stroke Protocol
  • 20-30mL daily for acute stroke
  • Started within 48 hours of event
  • 10-15 day initial course
  • Monitored in clinical setting
Sources

Study Citations

Cochrane Review
Cerebrolysin for acute ischaemic stroke
Ziganshina LE, et al.Cochrane Database Syst Rev, 2023
PMID: 37818733
Cochrane Review
Cerebrolysin for vascular dementia
Chen N, et al.Cochrane Database Syst Rev, 2013
PMID: 23440834
Review
Cerebrolysin: a review of its pharmacology and clinical use
Albrecht E, et al.Expert Opin Pharmacother, 2013
Bottom Line

Key Takeaways

✅ What We Know
  • 200+ clinical studies published
  • Approved in 40+ countries for stroke, TBI, dementia
  • Possible cognitive benefit in mild-moderate vascular dementia (Cochrane, limited evidence)
  • Generally well-tolerated with mild side effects
  • Multiple neurotrophic factors in one preparation
⚠️ What We Don't Know
  • Not FDA approved — unavailable in US pharmacies
  • Requires injection (IV/IM), not oral
  • Most trials from Eastern Europe (less Western data)
  • Long-term effects beyond 6-12 months unclear
  • Requires prescription and medical supervision

Support supplements if pursuing Cerebrolysin therapy (must be prescribed).

🐟 Omega-3 Fish OilBrain health foundation — support neural membranes☀️ Vitamin D3Neuroprotection and immune support💊 Magnesium GlycinateSupports neurological function
🧬
Dihexa Research
HGF/c-Met activator — experimental but promising
→💊
Noopept Guide
Russian cognitive enhancer — oral option
→🎯
Nootropic Stack Guide
Full stacking protocols
→📚
Nootropics Directory
All cognitive enhancers
→
📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.


Get the Guide →
⚠️ Disclaimer

Cerebrolysin is NOT FDA approved and not available in US pharmacies. It requires prescription and must be administered by medical professionals via IV/IM injection. This page is for educational purposes only. Always consult a qualified healthcare provider. Not Available in US Approved 40+ Countries